Scarica l'app Stockscreener
0.0757
36.92%
-0.0443
Dopo l'orario di chiusura:
.08
0.0043
+5.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.12
Aprire:
$0.0811
Volume 24 ore:
49,094
Relative Volume:
41.09
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-16.08M
Rapporto P/E:
-0.0022
EPS:
-34.43
Flusso di cassa netto:
$-11.54M
1 W Prestazione:
-36.92%
1M Prestazione:
-36.92%
6M Prestazione:
-86.27%
1 anno Prestazione:
-97.18%
Intervallo 1D:
$0.0735
$0.0811
Intervallo di 1 settimana:
$0.0735
$0.0811
Portata 52W:
$0.0735
$0.12
Bio Path Holdings Inc Stock (BPTH) Company Profile
Nome
Bio Path Holdings Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BPTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BPTH
Bio Path Holdings Inc
|
0.0757 | 0 | 0 | -16.08M | -11.54M | -34.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-11 | Iniziato | ROTH Capital | Buy |
| 2017-11-13 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-10 | Reiterato | Maxim Group | Buy |
| 2016-04-18 | Iniziato | Rodman & Renshaw | Buy |
| 2014-06-02 | Ripresa | Maxim Group | Buy |
| 2014-05-09 | Iniziato | Maxim Group | Buy |
Mostra tutto
Bio Path Holdings Inc Borsa (BPTH) Ultime notizie
Is Tevogen Bio Holdings Inc. stock a top pick in earnings seasonForecast Cut & Growth-Oriented Investment Plans - newser.com
Cutaneous T Cell Lymphoma Pipeline Drugs Insights Report 2025: - openPR.com
Comprehensive 2025 Chronic Myeloid Leukemia (CML) Treatment Market Intelligence: Navigate Expansion to 2034 - WhaTech
How Bio Path Holdings Inc. (IBP0) stock valuation compares with sectorJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
How supply shortages influence Bio Path Holdings Inc. (IBP0) stockTake Profit & Intraday High Probability Setup Alerts - newser.com
Bio-Path Holdings Provides Clinical and Operational Update - ADVFN
Antisense Oligonucleotides Market Trends Report 2025-2035, Profiles of Antisense Therapeutics, Biogen, Bio-Path, Ionis, ProQR, Sarepta, Sterna Biologicals, Wave Life SciencesResearchAndMarkets.com - The AI Journal
Will Supply Chain Issues Impact DUDigital Global Limiteds PerformancePrice Channel Trading & Free Extraordinary Earning Power - earlytimes.in
Is Bio Path Holdings Inc IBP0 a good long term investmentMorning Star Patterns & Rapid Portfolio Investment - earlytimes.in
Gossamer Bio Inc. stock trend outlook and recovery pathJuly 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Why Tevogen Bio Holdings Inc. stock remains a top recommendation2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
What drives Bio Path Holdings Inc IBP0 stock priceFundamental Strength Indicators & Exceptional Capital Trading - Early Times
What’s the recovery path for long term holders of Bio Techne CorporationMarket Performance Recap & Reliable Breakout Forecasts - newser.com
LeddarTech Holdings Inc. Equity Warrant stock trend outlook and recovery pathJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
What’s the recovery path for long term holders of Fortrea Holdings Inc.2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - Business Wire
Entera Bio Ltd. stock trend outlook and recovery path2025 Price Action Summary & Weekly High Return Forecasts - newser.com
When Will Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Turn A Profit? - simplywall.st
What’s the recovery path for long term holders of CERo Therapeutics Holdings Inc. Equity Warrant2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
MultiSensor AI Holdings Inc. Equity Warrant stock trend outlook and recovery pathNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Euro Tech Holdings Company Limited stock trend outlook and recovery pathEarnings Miss & AI Forecast Swing Trade Picks - newser.com
What’s the recovery path for long term holders of GoodRx Holdings Inc.2025 Support & Resistance & Growth Focused Investment Plans - newser.com
What’s the recovery path for long term holders of Boundless Bio Inc.Portfolio Value Report & Accurate Buy Signal Notifications - newser.com
Equitable Holdings Inc. stock trend outlook and recovery pathJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Passage Bio Inc. stock trend outlook and recovery pathInsider Buying & Fast Gain Stock Trading Tips - newser.com
What’s the recovery path for long term holders of Boot Barn Holdings Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Hayward Holdings Inc. stock trend outlook and recovery path2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
NYXH stock trend outlook and recovery pathWatch List & Verified Technical Trade Signals - newser.com
Allison Transmission Holdings Inc. stock trend outlook and recovery pathJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
What’s the recovery path for long term holders of MARA Holdings Inc.Market Movers & Low Drawdown Momentum Ideas - newser.com
What’s the recovery path for long term holders of bluebird bio Inc.Earnings Overview Report & Accurate Technical Buy Alerts - newser.com
What’s the recovery path for long term holders of Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
What’s the recovery path for long term holders of Nuvation Bio Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Marginal Zone Lymphoma Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential - openPR.com
Bio Path Holdings Inc Azioni (BPTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Capitalizzazione:
|
Volume (24 ore):